Genmab — December 2019

[bibob]

Ifm. DNB's sænkning har de samtidig hævet kursmålet til 1685 fra 1630.

[Solsen]

The drug is a huge success that we only could have dreamed of.

[Solsen]

With that we sleep all night.

[DevOp]

If the gradual release of the sc version of cd3xcd20 means a reduced risk of CRS and Gen's cd2xcd20 also has stronger potency than the competition - what's not to like

[Helge_LarsenPI-redaktør]

E L. I agree. I was blown away by all the amazing tweets about daratumab on Monday evening and night. They came from many of the leading experts in MM.

[Solsen]

Roches drug has only 1,1% grade 3 in CRS. Only one pts in Genmabs drug and they are byond.

[JKY_VH]

det skulle da lige være eksekvering ift partneraftale DevOp

[Solsen]

So that could be close and we dont se responses like Roches drug yet. But it can come.

[Solsen]

Iam not pessimist. But its not s homerun.

[Helge_LarsenPI-redaktør]

wsj.com

(www.wsj.com)

[mollegade]

Genmabs børsværdi ligger marginalt over 100 milliarder dkk, ikke sandt? Det er i så fald ca. 6 gange mere end de to handler, vi har set de sidste par dage. Men spændende med opkøb

[E_L]

https://twitter.com/SLentzsch/status/1204420825442668544

[bibob]

God morgen.

[DevOp]

God morgen! skal vi så ha' noget julerally...

[DevOp]

@JKY_VH: Fuldstændig enig, vi har ventet i efterhånden meget lang tid på en ny partneraftale. Det kunne godt se ud til, at vi skal et godt stykke ind i fase II for at BP bider på en 50/50 aftale. Men hellere det end en 10/90 eller en 20/80 aftale...

[transalp]

Go morgen..

[Parasitism]

God morgen

[Vitus]

Ikke megen julestemning over Genmab....

[nohope]

Trist -

[Sukkeralf]

Fyrværkeri med våd lunte - det er vi vist ved at være normalen